Russian Journal of AllergyRussian Journal of AllergyРоссийский Аллергологический Журнал1810-88302686-682XPublishing House ABV Press106410.36691/RJA1064ArticlesСтатьиAllergen-specific immunotherapy in children, and the perspectives of the methodСовременные методики аллерген-специфической иммунотерапии у детей и пути совершенствования методаTrusovaOl'ga Valer'evnaТрусоваОльга Валерьевна

Государственное общеобразовательное учреждение высшего постдипломного образования Санкт-Петербургская государственная педиатрическая медицинская академия Росздрава

o-tru@mail.ruGaydukI MГайдукИ М

Государственное общеобразовательное учреждение высшего постдипломного образования Санкт-Петербургская государственная педиатрическая медицинская академия Росздрава

KorostovtsevD SКоростовцевД С

Государственное общеобразовательное учреждение высшего постдипломного образования Санкт-Петербургская государственная педиатрическая медицинская академия Росздрава

TrusovaО VGaidukI MKorostovtsevD SГосударственное общеобразовательное учреждение высшего постдипломного образования Санкт-Петербургская государственная педиатрическая медицинская академия Росздрава1508200964NO4 (2009)№4 (2009)586610032020Copyright ©; 2009, Pharmarus Print MediaCopyright ©; 2009, Фармарус Принт Медиа2009Pharmarus Print MediaФармарус Принт Медиаhttps://rusalljournal.ru/raj/article/view/1064

The review is devoted to the latest results of scientific research and clinical trials in the field of allergen-specific immunotherapy (ASIT) in children, supported by the WHO and EAACI. The results of clinical trials of novel allergo-vaccines in Russian Federation are presented. The future perspectives in ASIT are reviewed.

В обзоре представлены основные результаты научных и клинических исследований по проведению аллерген-специфической иммунотерапии (АСИТ) у детей, поддержанные ВОЗ и Европейской академией аллергологии и клинической иммунологии (EAACI). Описаны результаты клинических испытаний принципиально новых типов стандартизованных лечебных аллергенов, внедренных в практическую аллергологию в Российской Федерации. Дан также обзор перспектив совершенствования АСИТ.

allergen-specific immunotherapychildrenаллерген-специфическая иммунотерапиядетиWHO position paper. Allergen immunotherapy: therapeutic vaccines for allergic diseases. Allergy. 1998, v. 53, Suppl. 44. p. 1-42.Standards for practical allergen-specific immunotherapy. Allergy. 2006, v. 61, Suppl. 82, p. 1-20.Purello-D'Ambrosio F., Gangemi S., Merendino R.A. et al. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy or nor. A retrospective study. Clin. Exp. Allergy. 2001, v. 31, p. 1295-1302.Eng P.A., Reinhold M., Gnehm H.P.E. Long-term efficacy of preseasonal grass pollen immunotherapy in children. Allergy. 2002, v. 57, p. 306-312.Di Rienzo V., Marcucci F., Puccinelli P. et al. Long-lasting effect of sublingual immunotherapy in children with asthma due to house dust mite: a 10-year prospective study. Clin. Exp. Allergy. 2003, v. 33, p. 206-210.Jacobsen L., Niggemann В., Dreborg S. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007, v. 62, p. 943-948.Alvarez-Cuesta E., Berges-Gimeno P., Mancebo E. G. et al. Sublingual immunotherapy with a standardized cat dander extract: evaluation of efficacy in a double blind placebo controlled study. Allergy. 2007, v. 62, p. 810-817.Ozdemir C., Yazi D., Gocmen I. et al. Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatric Allergy and Immunology. 2007, v. 18, p. 508-515.Lue K.-H., Lin Y.-H., Sun H.-L. et al. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study. Pediatric Allergy and Immunology. 2007, v. 17, p. 408-415.Bussmann C., Maintz L., Hart J. et al. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study. Clin. Exp. Allergy. 2007, v. 37, p. 1277-1285.Rolinck-Werninghaus C., Wolf H., Liebke C. et al. A prospective, randomized, double-blind, placebo-controlled multi-centre study on the efficacy and safety of sublingual immunotherapy (SLIT) in children with seasonal allergic rhinoconjunctivitis to grass pollen. Allergy. 2004, v. 59, p. 1285-1293.Fiocci A., Paino G., La Grutta S. et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann. Allergy Asthma Immunol. 2005, v. 95, p. 254-258.Di Rienzo V., Minelli M., Musarra A. et al. Post-marketing survey on the safety of sublingual immunotherapy in children below the 5 years of age. Clin. Exp. Allergy. 2005, v. 35. p. 560-564.Passalacqua G., Musarra A., Pecora S. et al. Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year). Pediatr. Allergy Immunol. 2007, v. 18, p. 58-62.Marsh D.G., Lichtenstein L.M., Campbell D.H. Studies on „Allergoids" prepared from naturally-occurring allergens. I. Assay of allergenicity and antigenicity of formalized rye Group I allergen Immunol. 1970, v. 18, p. 705-720.Шевелюк (Гайдук) И.М. Клинико-эпидемиологические особенности поллинозов у детей Санкт-Петербурга. Автореф. диссертации канд. мед. наук. СПб., 2001, 19 с.Bousquet J., Van Cauwenberge P., Khaltaev N. et al. Allergic rhinitis and its impact on asthma. J. Allergy Clin. Immunol. 2001, v. 108, p. S147-S334.Allergic rhinitis and its impact on asthma 2008 Update. Allergy. 2008, v. 63, Suppl. 86, p. 8-160.Calamita Z., Saconato H., Pela A.B., Atallah A.N. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy. 2006, v. 61, p. 1162-1172.Bousquet J., Demoly P. Specific immunotherapy - an optimistic future. Allergy. 2006, v. . 61, p. 1155-1158.Wilson D.R., Lima M.T., Durham S.R. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy. 2005, v. 60, p. 4-12.Pham-Thi N., Scheinmann P., Fadel R. et al. Assessment of sublingual immunotherapy efficacy in children with house-dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures. Pediatr. Allergy Immunol. 2007, v. 18, p. 47-57.Ревякина В.А., Арсентьева Н.А., Филатова Т.А. Эффективность аллерген-специфической иммунотерапии пероральными аллергенами «Весенняя смесь ранняя» у детей с поллинозом. Рос. Аллергол. Журн., 2007. Приложение. Сборник тематических статей «Сублингвальная аллерген-специфическая иммунотерапия». С. 31-38.Patel P., Salapatek A.M.F. Pollinex® Quattro: a novel and well-tolerated, ultra-short course allergy vaccine. Expert Review of Vaccines. 2006, v. 5, p. 617-629.Bassi M., Angrissano A. Safety and tolerability of an ultrarush build-up phase sublingual immunotherapy in children. Allergy. 2008, v. 63, Suppl. 88, Abstr. 590.Calderon M.A., Birk A.O., Andersen J.S., Durham S.R. Prolonged preseasonal treatment phase with Grazax sublingual immunotherapy increases clinical efficacy. Allergy. 2007, v. 62, p. 958-961.Mauro M., Russello M., Alesina R. et al. Tolerability of cluster immunotherapy with an alum adsorbed mite extract. J. Allergy Clin. Immunol. 2005, v. 115, p. 266.Bochenska-Marciniak M., Kuprys-Lipinska I., Tworek D., Kuna P. Perennial vs preseasonal immunotherapy in the treatment of rhinoconjunctivitis in subjects allergic to grass pollen. Allergy. 2008, v. 63, Suppl. 88, Abstr. 1458.Keskin O., Tuncer A., Adalioglu G. et al. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis. Pediatric Allergy and Immunology. 2006, v. 17, p. 396-407.Eifan A.O., Keles S., Bahceciler N.N., Barlan I.B. Anaphylaxis to multiple pollen sublingual immunotherapy. Allergy. 2007, v. 62, p. 567-568.Ibanez M.D., Kaiser F., Knecht R. et al. Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children Pediatric Allergy and Immunology. Pediatr. Allergy Immunol. 2007, v. 18, p. 516-522.Van Overtvelt L., Lombardi V., Razafmdrasita A. et al. IL-10 Inducing adjuvants enhance sublingual immunotherapy efficacy in a murine asthma model. Int. Arch. Allergy Immunol. 2008, v. 145, p. 152-162.Razafindrasita A., Saint-Lu N., Mascarell L. et al. Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J. Allergy Clin. Immunol. 2007, v. 120, p. 278-285.Хаитов Р. М., Федосеева В.Н., Некрасов А.В. и соавт. Создание аллерговакцин на основе аллергоидов из пыльцы тимофеевки, березы, полыни и иммуномодулятора полиоксидония. Аллергия, астма и клин. иммунол. 1999, № 9, c. 22-24.Петров Р.В., Хаитов Р.М., Ильина Н.И. и соавт. Аллерготропины - препараты нового поколения для аллерген-специфической иммунотерапии. Рос. Aллергол. Журн. 2004, № 2, c. 13-19.Larche M. Peptide immunotherapy for allergic diseases. Allergy. 2007, v. 62, p. 325-331.Wild C., Wallner M., Hufnagl K. et al. A recombinant allergen chimer as novel mucosal vaccine candidate for prevention of multi-sensitivities. Allergy. 2007, v. 62, p. 33-41.Hartl A., Hochreiter R., Stepanoska T. et al. Characterization of the protective and therapeutic efficiency of a DNA vaccine encoding the major birch pollen major allergen Bet v. 1a. Allergy. 2004, v. 59, p. 65-73.Holt P.G., Sly P.D, Bjorksten B. et al. Prophylaxis of atopy and asthma in children. www.immunetolerance.org/research/ <http://www.immunetolerance.org/research/>allergy/trials/holt, просмотрено 26.05.2008.